Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Assets
Cash and due from banks	$ 6,414	$ 4,624
Interest bearing deposits with banks	202,622	216,903
Cash and cash equivalents	209,036	221,527
Investment securities available for sale, at fair value	5,236	5,551
Investment securities held to maturity, net of allowance for credit losses of $0 at March 31, 2025 and December 31, 2024 (fair value of $7,447 at March 31, 2025 and $7,492 at December 31, 2024)	9,104	9,209
Total investment securities	14,340	14,760
Loans, net of unearned income	1,883,175	1,868,153
Less: Allowance for credit losses	(33,091)	(32,573)
Net loans	1,850,084	1,835,580
Accrued interest receivable	10,111	9,659
Premises and equipment, net	5,597	5,316
Restricted stock	6,807	8,619
Bank owned life insurance (BOLI)	29,235	29,070
Deferred tax asset	9,095	9,113
Other real estate owned (OREO)	1,562	1,562
Other	5,988	7,030
Total assets	2,141,855	2,142,236
Deposits
Noninterest-bearing deposits	185,348	184,037
Interest-bearing deposits	1,481,333	1,447,013
Total deposits	1,666,681	1,631,050
FHLBNY borrowings	105,000	145,000
Subordinated debentures	43,348	43,300
Accrued interest payable	6,970	7,968
Other	13,914	14,845
Total liabilities	1,835,913	1,842,163
Shareholders' Equity
Preferred stock, 1,000,000 shares authorized, $1,000 liquidation value Series B non-cumulative convertible; 325 shares outstanding at March 31, 2025 and December 31, 2024	325	325
Common stock, $0.10 par value; authorized 15,000,000 shares; Issued: 12,327,850 shares and 12,313,489 shares at March 31, 2025 and December 31, 2024, respectively	1,233	1,231
Additional paid-in capital	137,951	137,784
Retained earnings	173,995	168,347
Accumulated other comprehensive loss	(285)	(337)
Treasury stock, 484,522 shares at March 31, 2025 and December 31, 2024, at cost	(7,277)	(7,277)
Total shareholders’ equity	305,942	300,073
Total liabilities and shareholders' equity	$ 2,141,855	$ 2,142,236